Multiomic Approaches for Cancer Biomarker Discovery in Liquid Biopsies: Advances and Challenges
Biomark Insights. 2023 Oct 14;18:11772719231204508. doi: 10.1177/11772719231204508. eCollection 2023.ABSTRACTCancer is a complex and heterogeneous disease that poses a significant threat to global health. Early diagnosis and treatment are critical for improving patient outcomes, and the use of liquid biopsies has emerged as a promising approach for cancer detection and monitoring. Traditionally, cancer diagnosis has relied on invasive tissue biopsies, the collection of which can prove challenging for patients and the results of which may not always provide accurate results due to tumor heterogeneity. Liquid biopsies have g...
Source: Biomarker Insights - October 17, 2023 Category: General Medicine Authors: Paola Monterroso Diaz Ashton Leehans Prashanth Ravishankar Anna Daily Source Type: research

Multiomic Approaches for Cancer Biomarker Discovery in Liquid Biopsies: Advances and Challenges
Biomark Insights. 2023 Oct 14;18:11772719231204508. doi: 10.1177/11772719231204508. eCollection 2023.ABSTRACTCancer is a complex and heterogeneous disease that poses a significant threat to global health. Early diagnosis and treatment are critical for improving patient outcomes, and the use of liquid biopsies has emerged as a promising approach for cancer detection and monitoring. Traditionally, cancer diagnosis has relied on invasive tissue biopsies, the collection of which can prove challenging for patients and the results of which may not always provide accurate results due to tumor heterogeneity. Liquid biopsies have g...
Source: Biomarker Insights - October 17, 2023 Category: General Medicine Authors: Paola Monterroso Diaz Ashton Leehans Prashanth Ravishankar Anna Daily Source Type: research

Multiomic Approaches for Cancer Biomarker Discovery in Liquid Biopsies: Advances and Challenges
Biomark Insights. 2023 Oct 14;18:11772719231204508. doi: 10.1177/11772719231204508. eCollection 2023.ABSTRACTCancer is a complex and heterogeneous disease that poses a significant threat to global health. Early diagnosis and treatment are critical for improving patient outcomes, and the use of liquid biopsies has emerged as a promising approach for cancer detection and monitoring. Traditionally, cancer diagnosis has relied on invasive tissue biopsies, the collection of which can prove challenging for patients and the results of which may not always provide accurate results due to tumor heterogeneity. Liquid biopsies have g...
Source: Biomarker Insights - October 17, 2023 Category: General Medicine Authors: Paola Monterroso Diaz Ashton Leehans Prashanth Ravishankar Anna Daily Source Type: research

Multiomic Approaches for Cancer Biomarker Discovery in Liquid Biopsies: Advances and Challenges
Biomark Insights. 2023 Oct 14;18:11772719231204508. doi: 10.1177/11772719231204508. eCollection 2023.ABSTRACTCancer is a complex and heterogeneous disease that poses a significant threat to global health. Early diagnosis and treatment are critical for improving patient outcomes, and the use of liquid biopsies has emerged as a promising approach for cancer detection and monitoring. Traditionally, cancer diagnosis has relied on invasive tissue biopsies, the collection of which can prove challenging for patients and the results of which may not always provide accurate results due to tumor heterogeneity. Liquid biopsies have g...
Source: Biomarker Insights - October 17, 2023 Category: General Medicine Authors: Paola Monterroso Diaz Ashton Leehans Prashanth Ravishankar Anna Daily Source Type: research

Multiomic Approaches for Cancer Biomarker Discovery in Liquid Biopsies: Advances and Challenges
Biomark Insights. 2023 Oct 14;18:11772719231204508. doi: 10.1177/11772719231204508. eCollection 2023.ABSTRACTCancer is a complex and heterogeneous disease that poses a significant threat to global health. Early diagnosis and treatment are critical for improving patient outcomes, and the use of liquid biopsies has emerged as a promising approach for cancer detection and monitoring. Traditionally, cancer diagnosis has relied on invasive tissue biopsies, the collection of which can prove challenging for patients and the results of which may not always provide accurate results due to tumor heterogeneity. Liquid biopsies have g...
Source: Biomarker Insights - October 17, 2023 Category: General Medicine Authors: Paola Monterroso Diaz Ashton Leehans Prashanth Ravishankar Anna Daily Source Type: research

The Latest Developments in Using Proteomic Biomarkers from Urine and Serum for Non-Invasive Disease Diagnosis and Prognosis
Biomark Insights. 2023 Jul 29;18:11772719231190218. doi: 10.1177/11772719231190218. eCollection 2023.ABSTRACTDue to diagnostic improvements, medical diagnostics is demanding non-invasive or minimally invasive methods. Non-invasively obtained body fluids (eg., Urine, serum) can replace cerebral fluid, amniotic fluid, synovial fluid, bronchoalveolar lavage fluid, and others for diagnostic reasons. Many illnesses are induced by perturbations of cellular signaling pathways and associated pathway networks as a result of genetic abnormalities. These disturbances are represented by a shift in the protein composition of the fluids...
Source: Biomarker Insights - August 2, 2023 Category: General Medicine Authors: Anurag Shama Thomson Soni Ishwerpreet Kaur Jawanda Garima Upadhyay Anshika Sharma Vijay Prabha Source Type: research

The Latest Developments in Using Proteomic Biomarkers from Urine and Serum for Non-Invasive Disease Diagnosis and Prognosis
Biomark Insights. 2023 Jul 29;18:11772719231190218. doi: 10.1177/11772719231190218. eCollection 2023.ABSTRACTDue to diagnostic improvements, medical diagnostics is demanding non-invasive or minimally invasive methods. Non-invasively obtained body fluids (eg., Urine, serum) can replace cerebral fluid, amniotic fluid, synovial fluid, bronchoalveolar lavage fluid, and others for diagnostic reasons. Many illnesses are induced by perturbations of cellular signaling pathways and associated pathway networks as a result of genetic abnormalities. These disturbances are represented by a shift in the protein composition of the fluids...
Source: Biomarker Insights - August 2, 2023 Category: General Medicine Authors: Anurag Shama Thomson Soni Ishwerpreet Kaur Jawanda Garima Upadhyay Anshika Sharma Vijay Prabha Source Type: research

The Latest Developments in Using Proteomic Biomarkers from Urine and Serum for Non-Invasive Disease Diagnosis and Prognosis
Biomark Insights. 2023 Jul 29;18:11772719231190218. doi: 10.1177/11772719231190218. eCollection 2023.ABSTRACTDue to diagnostic improvements, medical diagnostics is demanding non-invasive or minimally invasive methods. Non-invasively obtained body fluids (eg., Urine, serum) can replace cerebral fluid, amniotic fluid, synovial fluid, bronchoalveolar lavage fluid, and others for diagnostic reasons. Many illnesses are induced by perturbations of cellular signaling pathways and associated pathway networks as a result of genetic abnormalities. These disturbances are represented by a shift in the protein composition of the fluids...
Source: Biomarker Insights - August 2, 2023 Category: General Medicine Authors: Anurag Shama Thomson Soni Ishwerpreet Kaur Jawanda Garima Upadhyay Anshika Sharma Vijay Prabha Source Type: research

The Latest Developments in Using Proteomic Biomarkers from Urine and Serum for Non-Invasive Disease Diagnosis and Prognosis
Biomark Insights. 2023 Jul 29;18:11772719231190218. doi: 10.1177/11772719231190218. eCollection 2023.ABSTRACTDue to diagnostic improvements, medical diagnostics is demanding non-invasive or minimally invasive methods. Non-invasively obtained body fluids (eg., Urine, serum) can replace cerebral fluid, amniotic fluid, synovial fluid, bronchoalveolar lavage fluid, and others for diagnostic reasons. Many illnesses are induced by perturbations of cellular signaling pathways and associated pathway networks as a result of genetic abnormalities. These disturbances are represented by a shift in the protein composition of the fluids...
Source: Biomarker Insights - August 2, 2023 Category: General Medicine Authors: Anurag Shama Thomson Soni Ishwerpreet Kaur Jawanda Garima Upadhyay Anshika Sharma Vijay Prabha Source Type: research

The Latest Developments in Using Proteomic Biomarkers from Urine and Serum for Non-Invasive Disease Diagnosis and Prognosis
Biomark Insights. 2023 Jul 29;18:11772719231190218. doi: 10.1177/11772719231190218. eCollection 2023.ABSTRACTDue to diagnostic improvements, medical diagnostics is demanding non-invasive or minimally invasive methods. Non-invasively obtained body fluids (eg., Urine, serum) can replace cerebral fluid, amniotic fluid, synovial fluid, bronchoalveolar lavage fluid, and others for diagnostic reasons. Many illnesses are induced by perturbations of cellular signaling pathways and associated pathway networks as a result of genetic abnormalities. These disturbances are represented by a shift in the protein composition of the fluids...
Source: Biomarker Insights - August 2, 2023 Category: General Medicine Authors: Anurag Shama Thomson Soni Ishwerpreet Kaur Jawanda Garima Upadhyay Anshika Sharma Vijay Prabha Source Type: research

The Latest Developments in Using Proteomic Biomarkers from Urine and Serum for Non-Invasive Disease Diagnosis and Prognosis
Biomark Insights. 2023 Jul 29;18:11772719231190218. doi: 10.1177/11772719231190218. eCollection 2023.ABSTRACTDue to diagnostic improvements, medical diagnostics is demanding non-invasive or minimally invasive methods. Non-invasively obtained body fluids (eg., Urine, serum) can replace cerebral fluid, amniotic fluid, synovial fluid, bronchoalveolar lavage fluid, and others for diagnostic reasons. Many illnesses are induced by perturbations of cellular signaling pathways and associated pathway networks as a result of genetic abnormalities. These disturbances are represented by a shift in the protein composition of the fluids...
Source: Biomarker Insights - August 2, 2023 Category: General Medicine Authors: Anurag Shama Thomson Soni Ishwerpreet Kaur Jawanda Garima Upadhyay Anshika Sharma Vijay Prabha Source Type: research

The Latest Developments in Using Proteomic Biomarkers from Urine and Serum for Non-Invasive Disease Diagnosis and Prognosis
Biomark Insights. 2023 Jul 29;18:11772719231190218. doi: 10.1177/11772719231190218. eCollection 2023.ABSTRACTDue to diagnostic improvements, medical diagnostics is demanding non-invasive or minimally invasive methods. Non-invasively obtained body fluids (eg., Urine, serum) can replace cerebral fluid, amniotic fluid, synovial fluid, bronchoalveolar lavage fluid, and others for diagnostic reasons. Many illnesses are induced by perturbations of cellular signaling pathways and associated pathway networks as a result of genetic abnormalities. These disturbances are represented by a shift in the protein composition of the fluids...
Source: Biomarker Insights - August 2, 2023 Category: General Medicine Authors: Anurag Shama Thomson Soni Ishwerpreet Kaur Jawanda Garima Upadhyay Anshika Sharma Vijay Prabha Source Type: research

The Latest Developments in Using Proteomic Biomarkers from Urine and Serum for Non-Invasive Disease Diagnosis and Prognosis
Biomark Insights. 2023 Jul 29;18:11772719231190218. doi: 10.1177/11772719231190218. eCollection 2023.ABSTRACTDue to diagnostic improvements, medical diagnostics is demanding non-invasive or minimally invasive methods. Non-invasively obtained body fluids (eg., Urine, serum) can replace cerebral fluid, amniotic fluid, synovial fluid, bronchoalveolar lavage fluid, and others for diagnostic reasons. Many illnesses are induced by perturbations of cellular signaling pathways and associated pathway networks as a result of genetic abnormalities. These disturbances are represented by a shift in the protein composition of the fluids...
Source: Biomarker Insights - August 2, 2023 Category: General Medicine Authors: Anurag Shama Thomson Soni Ishwerpreet Kaur Jawanda Garima Upadhyay Anshika Sharma Vijay Prabha Source Type: research

The Latest Developments in Using Proteomic Biomarkers from Urine and Serum for Non-Invasive Disease Diagnosis and Prognosis
Biomark Insights. 2023 Jul 29;18:11772719231190218. doi: 10.1177/11772719231190218. eCollection 2023.ABSTRACTDue to diagnostic improvements, medical diagnostics is demanding non-invasive or minimally invasive methods. Non-invasively obtained body fluids (eg., Urine, serum) can replace cerebral fluid, amniotic fluid, synovial fluid, bronchoalveolar lavage fluid, and others for diagnostic reasons. Many illnesses are induced by perturbations of cellular signaling pathways and associated pathway networks as a result of genetic abnormalities. These disturbances are represented by a shift in the protein composition of the fluids...
Source: Biomarker Insights - August 2, 2023 Category: General Medicine Authors: Anurag Shama Thomson Soni Ishwerpreet Kaur Jawanda Garima Upadhyay Anshika Sharma Vijay Prabha Source Type: research

The Latest Developments in Using Proteomic Biomarkers from Urine and Serum for Non-Invasive Disease Diagnosis and Prognosis
Biomark Insights. 2023 Jul 29;18:11772719231190218. doi: 10.1177/11772719231190218. eCollection 2023.ABSTRACTDue to diagnostic improvements, medical diagnostics is demanding non-invasive or minimally invasive methods. Non-invasively obtained body fluids (eg., Urine, serum) can replace cerebral fluid, amniotic fluid, synovial fluid, bronchoalveolar lavage fluid, and others for diagnostic reasons. Many illnesses are induced by perturbations of cellular signaling pathways and associated pathway networks as a result of genetic abnormalities. These disturbances are represented by a shift in the protein composition of the fluids...
Source: Biomarker Insights - August 2, 2023 Category: General Medicine Authors: Anurag Shama Thomson Soni Ishwerpreet Kaur Jawanda Garima Upadhyay Anshika Sharma Vijay Prabha Source Type: research